Literature DB >> 18602731

Exploring the cost-effectiveness of HPV vaccination in Vietnam: insights for evidence-based cervical cancer prevention policy.

Jane J Kim1, Katie E Kobus, Mireia Diaz, Meredith O'Shea, Hoang Van Minh, Sue J Goldie.   

Abstract

Using mathematical models of cervical cancer for the northern and southern regions of Vietnam, we assessed the cost-effectiveness of cervical cancer prevention strategies and the tradeoffs between a national and region-based policy in Vietnam. With 70% vaccination and screening coverage, lifetime risk of cancer was reduced by 20.4-76.1% with vaccination of pre-adolescent girls and/or screening of older women. Only when the cost per vaccinated girl was low (i.e., <I$25) was vaccination combined with screening (three times per lifetime or every 5 years) favored in both regions; at high costs per vaccinated girl (i.e., >I$100), screening alone was most cost-effective. When optimal policies differed between regions, implementing a national strategy resulted in health and economic inefficiencies. HPV vaccination appears to be an attractive cervical cancer prevention strategy for Vietnam, provided high coverage can be achieved in young pre-adolescent girls, cost per vaccinated girl is <I$25 (i.e., <$5 per dose), and screening is offered at older ages.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18602731     DOI: 10.1016/j.vaccine.2008.05.038

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  19 in total

1.  Finding consensus on cervical cancer prevention.

Authors:  Sue J Goldie; Meredith O'Shea; Jane J Kim
Journal:  Am J Public Health       Date:  2012-04-19       Impact factor: 9.308

2.  Cervical cancer screening in low-resource settings: A cost-effectiveness framework for valuing tradeoffs between test performance and program coverage.

Authors:  Nicole G Campos; Philip E Castle; Thomas C Wright; Jane J Kim
Journal:  Int J Cancer       Date:  2015-05-21       Impact factor: 7.396

3.  Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern Africa.

Authors:  Nicole G Campos; Jane J Kim; Philip E Castle; Jesse D Ortendahl; Meredith O'Shea; Mireia Diaz; Sue J Goldie
Journal:  Int J Cancer       Date:  2011-08-24       Impact factor: 7.396

4.  High-risk and multiple human papillomavirus infections among married women in Can Tho, Viet Nam.

Authors:  Lan Thi Hoang Vu
Journal:  Western Pac Surveill Response J       Date:  2012-07-31

5.  Longer term efficacy of a prophylactic monovalent human papillomavirus type 16 vaccine.

Authors:  Ali Rowhani-Rahbar; Constance Mao; James P Hughes; Frances B Alvarez; Janine T Bryan; Stephen E Hawes; Noel S Weiss; Laura A Koutsky
Journal:  Vaccine       Date:  2009-07-30       Impact factor: 3.641

6.  Is Pap Test Awareness Critical to Pap Test Uptake in Women Living in Rural Vietnam?

Authors:  Hee Yun Lee; Qingyi Li; Yan Luo; Kun Wang; Sara Hendrix; Jongwook Lee; Sangchul Yoon; Quoc Huy Nguyen Vu
Journal:  Asian Pac J Cancer Prev       Date:  2021-03-01

Review 7.  The cost effectiveness of human papillomavirus vaccines: a systematic review.

Authors:  Katherine Seto; Fawziah Marra; Adam Raymakers; Carlo A Marra
Journal:  Drugs       Date:  2012-03-26       Impact factor: 11.431

8.  Cost-effectiveness of different human papillomavirus vaccines in Singapore.

Authors:  Vernon J Lee; Sun Kuie Tay; Yee Leong Teoh; Mei Yin Tok
Journal:  BMC Public Health       Date:  2011-03-31       Impact factor: 3.295

9.  Comparative evaluation of the potential impact of rotavirus versus HPV vaccination in GAVI-eligible countries: a preliminary analysis focused on the relative disease burden.

Authors:  Sun-Young Kim; Steven Sweet; Joshua Chang; Sue J Goldie
Journal:  BMC Infect Dis       Date:  2011-06-16       Impact factor: 3.090

Review 10.  Aspects of prophylactic vaccination against cervical cancer and other human papillomavirus-related cancers in developing countries.

Authors:  Kari Natunen; Johannes Lehtinen; Proscovia Namujju; John Sellors; Matti Lehtinen
Journal:  Infect Dis Obstet Gynecol       Date:  2011-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.